A scientific review of cannabis will be carried out by the World Anti-Doping Agency to establish whether the substance should be removed from the prohibited list.
The World Anti-Doping Agency (Wada) recently announced it would conduct a scientific review of cannabis to determine whether it should be removed as a banned substance following a number of requests.
The organisation’s Executive Committee (ExCo) made the announcement at its third meeting of the year in Istanbul, noting that use of the plant would remain prohibited until a decision is made in 2022.
Currently, cannabinoid substances are prohibited with the exception of CBD, which is often used by athletes to aid recovery from sports injuries.
The Wada website states: “All natural and synthetic cannabinoids are prohibited except for cannabidiol (CBD). Cannabis, hashish and marijuana are prohibited.
“Products, including foods and drinks, containing cannabinoids, are also prohibited. All synthetic cannabinoids that mimic the effects of THC are prohibited.
“CBD is not prohibited; however, athletes should be aware that some CBD oils and tinctures extracted from cannabis plants, may also contain THC and other cannabinoids that could result in a positive test for a prohibited cannabinoid.”
Commenting on the decision Wada stated: “…following receipt of requests from a number of stakeholders, the ExCo endorsed the decision of the List Expert Advisory Group to initiate in 2022 a scientific review of the status of cannabis. Cannabis is currently prohibited in competition and will continue to be in 2022.”
The decision follows the ban of Sha’Carri Richardson from the Tokyo games after testing positive for THC. The US sprinter said on the Today Show that she used the substance to cope with the loss of her mother.
Speaking at the time of Richardson’s ban, U.S. Anti-Doping Agency (USADA) CEO, Travis Tygart, commented: “Regarding the way in which THC positives are handled, the World Anti-Doping Agency (WADA) sets the rules for the world that all countries—including the United States—have to follow. While the U.S. government has a seat at the table to provide feedback, and will continue to speak up for athletes, we are ultimately bound to the WADA rules. This is true even in sad and tough cases like this one, where we might take a different approach if the choice was ours to make.”
And continued: “While the rules here are clear, it is a terrible situation. Of course, it is important to emphasize that, as Sha’Carri said, she takes full responsibility and ownership of the decision to use marijuana despite knowing it was a risk. She learned about those risks during in-person education with USADA on multiple occasions, and several times she completed our online education modules, all of which address marijuana.
“None of this makes the situation any easier, as the real issue here is trying to find ways to support athletes who find themselves dealing with mental health issues similar to hers, where she decided that the use of marijuana was her only option to deal with her emotional pain even though it could easily put her career at risk.”
Cannabis regulation changes across Switzerland and Luxembourg
It is hoped that the changes will move consumers away from the black market.
This week both Switzerland and Luxembourg have announced changes to cannabis regulation.
Both Switzerland and Luxembourg have been signaling that legislation changes surrounding cannabis would be implemented but have delayed implementation up until this week, when Switzerland announced recreational and medical cannabis will be legalised, and Luxembourg announced it would allow home cultivation.
The moves have been catalysed by the desire to protect youth and move consumers away from the black market.
Changes in Switzerland
In Switzerland, the Social Security and Public Health Commission of the Council of States (CSSS-E) has said it is lifting the ban on cannabis and reviewing regulations relating to cannabis cultivation, production, trade and consumption.
The changes were approved by nine votes to two, with the CSSS-E supporting the initiative saying that it will be “regulating the cannabis market to better protect young people and consumers”, enabling legislative work to begin to create a regulated market. It aims to stem the black market and ensure that only cannabis which has been checked for quality is available.
The CSSS-E has said it is essential that the National Council takes into account the results of the pilot projects underway on the non-medical use of cannabis, citing that “the international context must also be taken into account.”
Changes in Luxemburg
Luxembourg announced plans to legalise recreational cannabis three years ago but has delayed on the matter. However, the country made the announcement on Friday (22 October) that citizens would be able to cultivate cannabis at home for personal use.
The deal struck in 2018 set the stage for legislation of recreational cannabis to be drawn up with the goal of impunity or legalisation regarding production in the country, as well consumption of cannabis for personal use, and for a national production and sales chain to be introduced under state control, with product quality assurance.
The deal said that the revenues from cannabis sales would be given priority into prevention, education and healthcare, and invested in the field of addiction.
The new announcement set out that citizens would be able to grow up to four plants, and that seed trade would be allowed, however, public consumption of cannabis remains illegal.
Malta’s Minister Bonnici presents first reading on cannabis reform
Malta’s Minister for Reform, Owen Bonnici has tabled the first reading of the government’s proposed cannabis reforms.
In a tweet, Malta’s Minister Owen Bonnici said the bill would ‘establish a new legal framework governing responsible use of cannabis. The government is proposing full decriminalisation for adults in possession of 7g or less for personal use. It would also mean proceedings would take place in front of the Commissioner for Justice rather than the criminal court for those with more than 7g but less than 28g.
Those proceedings may lead to fines between €50 to €100.
The white paper allows the cultivation of up to four plants per household and the expungement of cannabis-related criminal records. It would also mean the establishment of a Cannabis Authority.
Today I have presented the 1st reading of a bill that will establish a new legal framework governing responsible use of cannabis.
This important reform will keep showing @MaltaGov‘s unwavering and determined commitment to continue to be at the forefront of progressive change.
— •Owen Bonnici (@OwenBonnici) October 4, 2021
Malta’s commitment to change
Bonnici said the ‘important reform’ would show ‘unwavering and determined commitment’ to progressive change within the country.
The bill has not yet been published, but it stands as an upshot of a white paper. The cannabis reform white paper had more than 350 submissions from the public and organisations when the public consultation closed in May 2020.
The government also promised that there will be a legal course of procurement however this has not been clarified. Minister Bonnici was in charge of the 2015 decriminalisation bill which saw possession of 3.5g for personal use depenalised.
The Prime Minister had also promised that it will include a legal course of procurement, but it has not been clarified what it would be as yet. Malta’s Labour party stressed they wanted people to not resort to having contact with criminals but suggested the establishment of regulated cannabis social clubs similar to Barcelona where it is legal to consume cannabis. They also suggested an outlet where it is legal to buy seeds.
Malta’s ADPD, the green party, called for a more humane drug policy stating that the war on drugs has been a failure that has ruined people’s lives.
They stated: “Regulating cannabis, which is different from other substances, makes more sense than panic and control over thousands of people who use this substance.
“It should be possible for cannabis and seeds to be purchased legally, under reasonable controls, from shops specially licensed for this purpose. Processed products should be subject to the same taxation as other processed ‘smoked’ products such as cigarettes and tobacco.”
They are also in favour of a Spanish-style social club for cannabis users.
Malta’s cannabis opposition
The government anti-addiction agency, Sedqa opposes the legalisation of any psychoactive substances. They said that the government may as well consider legalisation if they allow the cultivation of cannabis plants at home.
Caritas, Oasi and the Malta Psychiatric Association issued a joint statement stating that the paper ran the risk of normalising the use of cannabis and further harming the island. They encouraged the government to adopt a ‘harm reduction approach that focuses on prevention, education and treatment.’
By Caroline Barry
Transforming London’s cannabis expertise into a world-leading industry
In this article, Hamish Stewart, Chair of the London Cannabis Legalisation Commission, explores three steps London can take to transform its medical cannabis expertise into a world-leading industry.
Three steps to transform London’s cannabis expertise into a world-leading industry.
London’s medical cannabis research capabilities and cannabis investment advisory services are both world-class. It is time to turn the focus of this impressive expertise onto developing legal production and retail markets for London.
The UK is among the world’s largest growers of medical-grade cannabis, with centres of research excellence at Imperial College and King’s College, among other institutions. This year, the Mayor of London has a unique opportunity to work with these academic partners and legal experts to establish and promote simple and transparent laboratory standards for a new local cannabis production and retail industry. This is one of 20 recommendations contained in the London Cannabis Legalisation Commission study, submitted to the Mayor and London Assembly members this week.
The international experience with legal cannabis production and retail shows that laboratory testing is essential to support the public health and safety aims of legalisation, and will be important to ensure the integrity of the London cannabis labelling system. Specifically, mandatory product testing supported by medical cannabis experts at Imperial College combined with clear labelling would minimise the risk of contaminated products entering the London cannabis market. The Commission recommends that the Mayor of London publish a model cannabis regulation that can then be adopted by interested London councils to pilot legal cannabis production and retail. The model regulation would include a process for quality control and laboratory testing.
Drawing on the existing capacity within London’s research university network including Imperial’s Medical Cannabis Research Group would help local consumers and market regulators make informed decisions. London is in the fortunate position of having laboratory standards for cannabis as part of the existing medical cannabis programme and these skills and expertise can support the scaling up of pilot production and retail programmes.
In addition to bringing medical cannabis expertise to bear on supporting quality control in a new legal industry, it will be important for the Mayor and London councils to act swiftly to build additional capacity. The Mayor should communicate an accelerated plan to:
Start cannabis industry training programmes for youth in advance of launching London councils cannabis production and retail pilots in 2022. There are significant opportunities for formal employment in the London cannabis industry, with the growing, retail, processing and distribution segments all having high job creation potential. A formalised job training programme for London cannabis business sub-sectors would benefit businesses looking for skilled workers. Cannabis vocational training would also boost progress on the Mayor’s social equity goals, and this is one goal of our London Cannabis Academy. Those who will be enforcing the new cannabis regulatory regime, mostly London councils, and the police where necessary, will also need proper training to fulfil these new roles in a legal cannabis market. While all London councils will be involved in training officials within their respective jurisdictions, the Mayor of London’s model cannabis regulation should establish guidelines and develop standardised content for in-person and digital training.
The illicit cannabis industry is already well developed in London, so shifting this supply chain into the legal market should be a priority. Tracking this progress will require baseline information. The Mayor of London and his team should:
Monitor and evaluate the new legal cannabis industry from the beginning. Data will be needed to track the evolution of the new system to understand if it is successfully displacing illicit supply, helping to dampen youth violence, and generate employment and local business opportunities. Analysis that compares data gathered under the new system against baseline data will help regulators determine whether London is on track to achieve the goal of reducing profits of the illicit industry and associated youth violence, and build a world-class cannabis industry that empowers Londoners. Timely data collection, evaluation and reporting of results on a pan-London basis will be key to the successful development of London councils pilot programmes.
The Mayor should proactively communicate London’s leadership plans. Clear communication is necessary to provide Londoners with the information they need to understand the regulated system and the intended contents of a model regulation. London First and the Mayor’s office should prepare to provide all Londoners with the facts about cannabis and its effects, alongside specific information and guidance to the different groups involved in the regulated cannabis market. Beyond London, the Mayor’s office should have a communications strategy to update the international community and global city networks on the content and timeline for implementation of cannabis pilot programmes and the model London cannabis regulation.
London Cannabis Legalisation Commission
- Life sciences company to expand into medical cannabis market
- European Medicines Agency gives cannabinoid medicine positive opinion
- Cannabis regulation changes across Switzerland and Luxembourg
- Cannabis investment company to see UK and Europe growth
- How COVID has and will continue to change the cannabis market